Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.

Abstract:

:YM466, a novel factor Xa inhibitor, is a hydrophilic compound with a carboxylic acid moiety. Previous studies in rats have shown that YM466 does nor undergo metabolism but is excreted into the bile and urine in unchanged form. Thus, in this study, we investigated in vivo hepatobiliary transport, focusing in particular on multidrug resistance-associated protein 2 (Mrp2/Abcc2)-mediated transport. The hepatobiliary transport of YM466 was investigated after its systemic infusion into Sprague-Dawley rats (SDRs) and Eisai hyperbilirubinemic rats (EHBRs), which lack Mrp2. When the binding of YM466 in the plasma and liver was examined, the bile-to-plasma concentration ratio and the liver-to-plasma concentration ratio for the unbound concentration in SDRs amounted to 32.2 and 2.83, respectively, suggesting concentrated transport. The bile-to-liver concentration ratio for the unbound concentration in EHBRs was not lower than that found for SDRs. These findings suggest that YM466 is excreted from the plasma into the bile in a concentrated manner; however, Mrp2 does not play a major role in biliary excretion.

authors

Mano Y,Usui T,Kamimura H

doi

10.1007/BF03191128

subject

Has Abstract

pub_date

2006-04-01 00:00:00

pages

117-21

issue

2

eissn

0378-7966

issn

2107-0180

journal_volume

31

pub_type

杂志文章
  • Influence of bile acid derivates on tramadol analgesic effect in mice.

    abstract::Influence of two newly synthesized bile acids derivates, namely sodium salt of monoketocholic acid MKH-Na and methyl ester of monoketocholic acid MKH-Me on tramadol (12.5 mg/kg oral and intramuscular) analgesic effect was examined in this research. Analgesic effect was measured by antinociceptive hot plate method. Int...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-010-0011-z

    authors: Vasovic V,Vukmirovic S,Pjevic M,Mikov I,Mikov M,Jakovljevic V

    更新日期:2010-09-01 00:00:00

  • The role of drug lipophilicity in release from intra-adipose and intramuscular injection sites.

    abstract::Release rates from intramuscular and intra-adipose injection sites are dependent upon several including injection depth. Little is known about the relationship between drug lipophilicity and transport rate of drugs through adipose and muscle tissue. The principal objective of the present study was to investigate to wh...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Kadir F,Zuidema J,Pijpers A,Vulto A,Verheijden JH

    更新日期:1991-01-01 00:00:00

  • Febarbamate: metabolism in man.

    abstract::The biotransformation of 1-(3-butoxy-2-carbamoyloxypropyl)-5-ethyl-5-phenyl-(1H,3H,5H)-pyrimidine-2,4,6-trione (febarbamate) has been investigated in man. Human volunteers received a single oral dose of 15 mg/kg febarbamate. Twenty two metabolites found in urine were separated and purified by means of an extraction wi...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188760

    authors: Vachta J,Valter K,Gold-Aubert P

    更新日期:1983-07-01 00:00:00

  • Phenobarbital-digitoxin interaction in the guinea pig liver.

    abstract::The influence of phenobarbital pretreatment on liver concentration of digitoxin and its metabolites was studied in guinea-pigs after i.p. administration of the cardiac glycoside. During the first hour an increase in liver uptake was observed in pretreated animals. The differences detected in the hepatic subcellular di...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189562

    authors: Carvalhas ML,Figueira MA,Maya MR

    更新日期:1982-01-01 00:00:00

  • Prediction of Half-Life Extension of Peptides via Serum Albumin Binding: Current Challenges.

    abstract::The development of peptide therapeutics has increased enormously in recent decades. Many of the peptide drugs and antibody fragments that lack Fc backbone have a short half-life in circulation. In general, the half-life supports the design of the dosing regimen and frequency of administration, which are key aspects in...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00664-y

    authors: Hijazi Y

    更新日期:2021-01-01 00:00:00

  • Disposition of [3H]cloflumide, a new neuroleptic drug, in rats.

    abstract::The disposition of cloflumide (VUFB 15496), 2-chloro-7-fluoro-10 [4-(carbamoylethyl)piperazino]-10,11-dihydrodibenzo [b,f] thiepin methansulfonate, a new neuroleptic agent, following single oral and intravenous dose was studied in the rat using radiotracer techniques. [3H]Cloflumide was almost completely absorbed from...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189883

    authors: Lapka R,Franc Z,Smolík S

    更新日期:1987-04-01 00:00:00

  • Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application.

    abstract::Apomorphine was administered subcutaneously and intranasally to 7 patients suffering from Parkinsonism with 'on-off' problems. This comparative pharmacokinetic study showed that the two routes of administration are comparable with respect to absorption kinetics. Apomorphine is rapidly absorbed when administered intran...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF03192285

    authors: Sam E,Jeanjean AP,Maloteaux JM,Verbeke N

    更新日期:1995-01-01 00:00:00

  • Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model.

    abstract::Thymoquinone (THQ), the active constituent of Nigella sativa seeds, has demonstrated some potential pharmacological activities. The present study was designed to investigate the pharmacokinetic behavior of THQ following intravenous (IV) and oral (PO) administration using an animal model. THQ was given vascularly (5 mg...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-014-0207-8

    authors: Alkharfy KM,Ahmad A,Khan RM,Al-Shagha WM

    更新日期:2015-09-01 00:00:00

  • First pass effect of pinazepam in the rabbit liver.

    abstract::The liver first pass effect of pinazepam in four anaesthetized rabbits was determined by measuring the concentrations of this compound and those of its metabolite N-desmethyldiazepam in the plasma from the portal and hepatic veins. Anaesthesia was induced with an i.p. injection of urethane (1.5 g/kg). Portal and hepat...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188728

    authors: Pacifici GM,Placidi GF

    更新日期:1982-01-01 00:00:00

  • Solid-phase extraction of piribedil and its metabolites from plasma and urine without and after deconjugation, by high performance liquid chromatography.

    abstract::A new high performance liquid chromatographic procedure has been developed for the simultaneous quantification of piribedil (PD) and its three main basic metabolites in rat plasma and urine, without and after hydrolysis. The procedure relies on isolation of the compounds from plasma and urine constituents using the Se...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190147

    authors: Sarati S,Caccia S

    更新日期:1992-07-01 00:00:00

  • The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood-Brain Barrier in Rats.

    abstract:BACKGROUND AND OBJECTIVE:Sorafenib is an oral, multikinase inhibitor with established single-agent activity in several tumor types. Sorafenib was moderately transported by P-glycoprotein (P-gp) and more efficiently by breast cancer resistance protein. The constitutive androstane receptor (CAR) is a ligand-activated tra...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00639-z

    authors: Karbownik A,Stanisławiak-Rudowicz J,Stachowiak A,Romański M,Grześkowiak E,Szałek E

    更新日期:2020-12-01 00:00:00

  • Plasma protein binding of penbutolol in pregnancy.

    abstract::Penbutolol is a not cardioselective beta-adrenergic blocking drug; it is lipid soluble and differs in its protein binding from the other members of its group because shows linkage to alpha 1-glycoprotein, with no detectable binding to albumin. AAG levels change during pregnancy and so the binding of [3H]-penbutolol wa...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189924

    authors: Aquirre C,Rodriguez-Sasiain JM,Navajas P,Calvo R

    更新日期:1988-01-01 00:00:00

  • Urodynamic modeling of norfloxacin pharmacokinetics by means of computer simulation.

    abstract::Urodynamic model was developed which, in conjunction with a compartmental pharmacokinetic model, was used for study of factors influencing drug concentrations in urine: urine flow rate, residual bladder urine, maximal bladder urine, stage of renal failure, and elimination kinetics of drugs. Norfloxacin (NOR) was used ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Primozic S,Karba R,Mrhar A,Drinovec J,Kozjek F

    更新日期:1991-01-01 00:00:00

  • Isolation and determination of bile acids.

    abstract::In this article, the methods of isolation and determination of bile acids are reviewed. Methods for separation of bile acids from cattle and pig bile are given in detail. Isolation of a mixture of cholic acid and deoxycholic acids from cattle bile and their subsequent purification are described. The isolation and puri...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/BF03190712

    authors: Kandrac J,Kevresan S,Gu JK,Mikov M,Fawcett JP,Kuhajda K

    更新日期:2006-07-01 00:00:00

  • A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen.

    abstract::We retrospectively analyzed amikacin pharmacokinetics in 19 critically ill patients who received amikacin intravenously. Fourteen subjects (577 serum amikacin concentrations, 167 urine measurements) were studied to obtain data for population modeling, while 5 patients (267 serum amikacin concentrations, 68 urine measu...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190009

    authors: Joubert P,Bressolle F,Gouby A,Douçot PY,Saissi G,Gomeni R

    更新日期:1999-01-01 00:00:00

  • Intraocular penetration of fusidic acid with topical Fucithalmic.

    abstract::Fucithalmic is a newly developed 1% microcrystalline suspension of the antistaphylococcal antibiotic fusidic acid. Penetration into the eye was investigated in twenty patients about to undergo cataract extraction. A single dose produced median antibiotic levels in the aqueous humour of 0.3 mcg/ml, maintained for at le...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189761

    authors: Hansen S

    更新日期:1985-10-01 00:00:00

  • Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methyl glutaryl CoA reductase, on drug-metabolizing enzymes in rats.

    abstract::Fluvastatin (FV), a new cholesterol-lowering agent, has been studied for its effects on hepatic microsomal drug-metabolizing enzymes in male rats. FV was orally administered in dosages of 1, 5, and 30 mg/kg/day for 7 consecutive days. 3-Hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase activities were markedly decrease...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189669

    authors: Ohtawa M,Masuda N,Karasawa Y,Tojo H

    更新日期:1995-07-01 00:00:00

  • Renal elimination of the hypoxic cell radiosensitizer misonidazole in Wistar rats: influence of some drugs on its excretion.

    abstract::The hypoxic cell radiosensitizing drug, misonidazole (Miso) (Ro 07-0582) and its demethylated metabolite were administered to Wistar rats at different dose levels to examine their renal elimination. The data were consistent with a model in which Miso is eliminated mainly after biotransformation into desmethylmisonidaz...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189740

    authors: Akel G,Canal P,Soula G

    更新日期:1985-07-01 00:00:00

  • Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method.

    abstract::Changes in liver perfusion may have a substantial influence on the pharmacokinetics of drugs with flow-controlled metabolism. This may have important implications for drug dosage in patients in an intensive care unit (ICU). The hepatic D-sorbitol plasma clearance has been suggested as a non-invasive test for evaluatin...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190181

    authors: Köppel C,Pohle S,Müller C

    更新日期:1993-10-01 00:00:00

  • Study of the upregulation of the activity of cytochrome P450 3A isoforms by Astragalus injection and Astragalus granules in rats and in cells.

    abstract::Astragalus injection (AI) and Astragalus granules (AG) are the two representative clinical preparations from Astragali Radix. In order to investigate the regulation of metabolism, AI and AG were tested for their ability to affect the major enzyme cytochrome P450 3A isoforms in vivo and in vitro. In the study of CYP3A1...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-012-0102-0

    authors: Zhang Y,Huang L,Bi H,Cui Y,Li J,Wang X,Qin X,Chen J,Huang M

    更新日期:2013-06-01 00:00:00

  • Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.

    abstract::Metoprolol Oros tablets were designed to deliver their drug content as a constant rate over a period of time longer than that currently recorded with slow-release dosage forms. The bioavailability of 7/95, 14/190 and 21/285 Oros tablets was compared to that of either 100 mg conventional or 200 mg slow-release Lopresor...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188865

    authors: Richard J,Cardot JM,Godbillon J

    更新日期:1994-10-01 00:00:00

  • Effect of pomegranate juice on the pharmacokinetics of nitrendipine in rabbits.

    abstract::Pomegranate juice (PJ) is known to be a potent inhibitor of human cytochrome enzymes. The purpose of this study was to investigate the effect of acute and chronic PJ on the pharmacokinetics of oral nitrendipine (10 mg/kg) in rabbits. Male New Zealand rabbits were pretreated with PJ for 1 week and on the last day, a si...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-011-0075-4

    authors: Voruganti S,Rapolu K,Tota S,Yamsani SK,Yamsani MR

    更新日期:2012-06-01 00:00:00

  • Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits.

    abstract::The purpose of this study was to determine the distribution of cyclosporin A (CsA) in various ocular fluids and tissues in the rabbit by two routes of administration. CsA was administered to two groups of two rabbits either by intramuscular route at a dose of 25 mg/kg/day or by local route using eyedrops, at a dose of...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Vernillet L,Lundh RL,Acezat-Mispelter F,Goizel C,Humbert H,Pouliquen Y

    更新日期:1991-01-01 00:00:00

  • Inducibility of rat brain drug-metabolizing enzymes.

    abstract::Cytochrome P450 from rat brain mitochondrial and microsomal fractions was found to be inducible by 3-methylcholanthrene, both in quantity of enzyme and in activity towards 7-ethoxyresorufin, which is a model substrate for the cytochrome P450 isoform specifically induced by 3-methylcholanthrene. Conversely, a phenobarb...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189910

    authors: Ghersi-Egea JF,Walther B,Perrin R,Minn A,Siest G

    更新日期:1987-10-01 00:00:00

  • The pharmacokinetics, tissue distribution, and biotransformation of a new class of antitumor agents: mitonafide and pinafide.

    abstract::The pharmacokinetics, biotransformation, protein binding and tissue distribution of mitonafide and pinafide were studied after single i.v. and oral administration of each drug (20 mg/Kg) in female rats. In pregnant rats a study of cross placental-barrier after i.v. administration of the two drugs was also performed. T...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189110

    authors: Rivera Cid P,Gonzalez Fernandez E,Martin FR,Braña MF

    更新日期:1986-10-01 00:00:00

  • Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses.

    abstract::This study investigated the effect of mibefradil on digoxin pharmacokinetics an pharmacodynamics. Following a loading dose of digoxin (0.375 mg, three times, day 1), 0.375 mg was administered once daily to 40 healthy subjects (days 2-15). Mibefradil was administered daily at 50 mg, 100 mg, or 150 mg (days 9-15). With ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF03190358

    authors: Peters J,Welker HA,Bullingham R

    更新日期:1999-04-01 00:00:00

  • Pharmacokinetic and pharmacodynamic data and models in clinical trials.

    abstract::There is current emphasis for extended integration of pharmacokinetics (PK) and pharmacodynamics (PD) into all phases of new drug development, including large-scale clinical trials. In this paper, we focus on study design and data analysis issues for the investigation of pharmacokinetic/pharmacodynamic and blood level...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/BF03220009

    authors: Steimer JL,Ebelin ME,Van Bree J

    更新日期:1993-01-01 00:00:00

  • Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice.

    abstract::Lisofylline (LSF), is the R-(-) enantiomer of the metabolite M1 of pentoxifylline, and is currently under development for the treatment of type 1 diabetes. The aim of the study was to develop a physiologically based pharmacokinetic (PBPK) model of LSF in mice and to perform simulations in order to predict LSF concentr...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-015-0260-y

    authors: Wyska E,Świerczek A,Pociecha K,Przejczowska-Pomierny K

    更新日期:2016-08-01 00:00:00

  • A comparative "in vitro" study of permeability with different synthetic and biological membranes.

    abstract::Permeability coefficients of seven compounds belonging to a true homologous series (4-alkylanilines) through several different synthetic and biological membranes were assayed in a two-chamber diffusion cell. Permeability-lipophilicity relationships for the experimental data were established and compared in order to as...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Díez-Sales O,Guzmán D,Cano D,Martín A,Sánchez E,Herráez M

    更新日期:1991-01-01 00:00:00

  • Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans.

    abstract::BACKGROUND AND OBJECTIVE: Efavirenz is commonly used in Africa and is frequently associated with neurocognitive toxicity, which may compromise clinical outcomes. Older individuals are at increased risk for drug toxicity and clinical outcomes may be worse in older age, particularly among those individuals with cytochro...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-018-0507-5

    authors: Torgersen J,Bellamy SL,Ratshaa B,Han X,Mosepele M,Zuppa AF,Vujkovic M,Steenhoff AP,Bisson GP,Gross R

    更新日期:2019-04-01 00:00:00